Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer (RAD)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Hallym University Medical Center
ClinicalTrials.gov Identifier:
NCT01046461
First received: January 8, 2010
Last updated: February 16, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)